Fair AMP Act
Official title: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the… Show full official titleShow less
Official title: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act
This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1785: Fair AMP Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-1785/
"S. 1785: Fair AMP Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-1785/.
S. 1785, 116th Cong. (2026), https://openamerica.io/bill/116-S-1785/.
[S. 1785: Fair AMP Act](https://openamerica.io/bill/116-S-1785/)